List of works by Robert C Seeger

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.

scientific article published on 18 June 2018

A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.

scientific article published on 14 October 2015

A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastoma

scientific article published on 01 February 1998

A novel minimal residual disease model of neuroblastoma in mice

scientific article published on 04 March 2016

A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies.

scientific article

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group

scientific article

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group

scientific article published on July 1997

A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases

scientific article published on 01 September 1991

A surgical perspective on the current staging in neuroblastoma--the International Neuroblastoma Staging System proposal

scientific article published in April 1989

Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma

scientific article published on 19 September 2018

Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group

scientific article

Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma

scientific article published on 01 September 1991

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

article

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma

article

Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.

scientific article published in November 1994

Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas

scientific article published on 01 October 1986

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

scientific article

Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage

scientific article published on 01 January 1985

Amplification units containing human N-myc and c-myc genes

scientific article published on February 1986

An analysis of variables affecting the measurement of tumor immunity in vitro with 125I-iododeoxyuridine-labelled target cells. Studies of immunity to primary Moloney sarcomas

scientific article published on 01 May 1974

An integrated cross-platform prognosis study on neuroblastoma patients

scientific article published on 30 July 2008

Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells

scientific article published on 08 May 2019

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

scientific article

Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma

scientific article published on 23 January 2012

Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and az

scientific article published in June 2002

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

article

Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study

scientific article

Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126.

scientific article published on 18 November 2016

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study

scientific article

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

scientific article published in March 2000

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study

scientific article published on January 2000

Biological classification of cell lines derived from human extra-cranial neural tumors

scientific article published on January 1, 1988

Biological roles and potential applications of immune cell-derived extracellular vesicles

scientific article

Bone abnormalities detected with skeletal scintigraphy after bone marrow harvest in patients with childhood neuroblastoma

scientific article published on 01 September 1994

Bone marrow transplantation for poor prognosis neuroblastoma

scientific article published in January 1988

Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line.

scientific article published on November 2001

CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus

scientific article published on 22 June 2015

Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells

scientific article

Cdc6 knockdown inhibits human neuroblastoma cell proliferation

scientific article published on 8 February 2008

Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells

scientific article published on 01 April 1992

Characterization of human neuroblastoma cell lines that lack N-myc gene amplification

scientific article published on 01 January 1988

Chromosome 1p and 11q deletions and outcome in neuroblastoma

scientific article

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

scientific article

Clinical implications of oncogene activation in human neuroblastomas

scientific article

Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma

scientific article published on 27 August 2012

Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma

scientific article published on 21 May 2018

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

scientific article published on October 2009

Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes

scientific article published on 07 May 2018

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity

scientific article

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

scientific article

Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.

scientific article published in January 1994

Comprehensive analysis of chromosome 1p deletions in neuroblastoma

article

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

scientific article published on 28 April 2009

Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients

scientific article published on 01 August 1987

Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies

scientific article published in September 1996

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931

scientific article published on 16 July 2018

Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma

scientific article published on 30 April 2013

Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma.

scientific article published on 6 March 2018

De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene

scientific article

Delayed surgery and bone marrow transplantation for widespread neuroblastoma

scientific article published on 01 October 1987

Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads

scientific article published on 01 January 1985

Detection of N-myc gene expression in neuroblastoma tumors by in situ hybridization.

scientific article published in June 1988

Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma

scientific article published in March 2001

Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors

scientific article published on 01 March 1998

Drug resistance in human neuroblastoma cell lines correlates with clinical therapy

scientific article

Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.

scientific article

Drugging MYCN through an allosteric transition in Aurora kinase A

scientific article

Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.

scientific article published in June 1998

Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index

scientific article

Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma

scientific article published in April 1993

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

article

Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.

scientific article

Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy

scientific article published on 01 February 1989

Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy

scientific article

Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells

scientific article published in June 2003

Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.

scientific article

Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene

scientific article published on 01 January 1988

Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors

scientific article published on February 2000

Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells

Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study

scientific article published in February 2000

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

scientific article

Fetal neural antigens on human neuroblastoma cells.

scientific article published in June 1980

GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma

scientific article published on 01 October 2004

Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization

scientific article published on January 1997

Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow

scientific article published on August 2001

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

scientific article published on 8 October 2010

Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy

scientific article published on February 2013

High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.

scientific article published in January 1994

High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification

scientific article

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group

scientific article published in November 2001

Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular

scientific article published in September 2000

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma

scientific article published on January 2001

Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group

scientific article

Hsp27 expression in neuroblastoma: correlation with disease stage

scientific article published on 01 May 1994

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells

scientific article

Human neuroblastoma cell lines that express N-myc without gene amplification.

scientific article published on December 1993

Identification and characterization of the protein encoded by the human N-myc oncogene

scientific article

Identification of Subsets of Neuroblastomas by Combined Histopathologic and N-myc Analysis ⬇️

scientific article published on October 4, 1995

Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens.

scientific article published in January 1985

Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study ⬇️

scientific article published on May 1, 2003

In vitro and in vivo preclinical chemotherapy studies of human neuroblastoma

scientific article published on 01 August 1980

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

scientific article published on July 1999

Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide

scientific article

Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma

scientific article published on 01 January 1991

Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells

scientific article published on January 2009

International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma

scientific article published on January 1, 1988

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

scientific article

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

scientific article published in March 1993

Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells

scientific article

Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1.

scientific article published on 27 August 2013

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

scientific article

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

article

Loss of heterozygosity for chromosome 14q in neuroblastoma

scientific article published on 01 January 2001

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group

scientific article published on 15 December 2017

MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma

scientific article published on 9 December 2015

Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis

scientific article published in May 1998

Membrane-bound TRAIL supplements natural killer cell cytotoxicity against neuroblastoma cells

scientific article

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

scientific article published on May 1999

Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads

scientific article

Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas.

scientific article published on January 1988

Molecular characterization of the pediatric preclinical testing panel

scientific article

More than the genes, the tumor microenvironment in neuroblastoma.

scientific article

Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines ⬇️

scientific article published on May 1, 1977

Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors

scientific article published in December 2000

Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.

scientific article published in January 1994

N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18).

scientific article published on November 1990

N-myc protein expression by neuroblastoma cells that have metastasized to bone marrow

scientific article published on 01 January 1988

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

scientific article

Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms

scientific article published on 12 December 2018

Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2

scientific article

Neuroblastoma in adults and adolescents: an indolent course with poor survival

scientific article

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group

scientific article

Neuroblastoma: clinical perspectives, monoclonal antibodies, and retinoic acid

scientific article published on December 1982

Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors

scientific article published on 01 September 1990

Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.

scientific article published on February 2000

Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.

scientific article

Onco-neural antigen: a new neural differentiation antigen expressed by neuroblastoma, oat cell carcinoma, Wilms' tumor, and sarcoma cells ⬇️

scientific article published on April 1, 1979

Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma

scientific article published in September 2007

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study

scientific article

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

scientific article

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

scientific article

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group

scientific article published on January 2009

PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors

scientific article published on 01 January 1993

Parental smoking and alcohol consumption and risk of neuroblastoma

scientific article published on 01 September 2000

Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.

scientific article published in November 1993

Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience

scientific article published in November 1995

Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group

scientific article

Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee

scientific article

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

scientific article

Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.

scientific article published in January 2006

Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group

scientific article published on December 2008

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's

scientific article published on 01 December 2000

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation

scientific article

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors

scientific article published on 9 February 2018

Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study

scientific article

Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.

scientific article

Prognostic impact of gene expression-based classification for neuroblastoma.

scientific article published on 21 June 2010

Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience

scientific article published in June 1985

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification

scientific article published in September 2006

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

scientific article published on 01 January 1991

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

scientific article published on 25 July 2013

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

scientific article published in December 2000

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group. ⬇️

scientific article published on 16 December 2016

Removal of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads

scientific article published on 01 January 1986

Residential Pesticide Exposure and Neuroblastoma

article

Response of neuroblastoma to retinoic acid in vitro and in vivo

scientific article published on January 1991

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

scientific article published on 17 September 2014

Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group results ⬇️

scientific article published on January 1, 1995

Sensitive detection of neuroblastoma cells in bone marrow for monitoring the efficacy of marrow purging procedures

scientific article published on 01 January 1985

Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma

scientific article published on 13 August 2020

Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis

scientific article

Sparse representation and Bayesian detection of genome copy number alterations from microarray data

scientific article

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study

scientific article published in April 1998

TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells

scientific article published on 10 October 2016

Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma

scientific article published in December 2000

Telomerase expression in primary neuroblastomas

scientific article

The International Neuroblastoma Risk Groups (INRG): a preliminary report

scientific article published on October 1997

The MYCN enigma: significance of MYCN expression in neuroblastoma

scientific article published on March 2006

The genetic landscape of high-risk neuroblastoma

scientific article published on 20 January 2013

The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis

scientific article

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

scientific article

Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation

scientific article published on April 1991

Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro

scientific article published on January 1994

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance

scientific article

Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages

scientific article published on June 2009

Variability in DNA distributions of human neuroblastomas after cyclophosphamide

scientific article published on 01 January 1980

Volumetric and functional heterogeneity of human monocytes

scientific article published on March 1980

Wavelet Footprints and Sparse Bayesian Learning for DNA Copy Number Change Analysis

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome

scientific article

Paulina is supported by:

About Paulina

Help